Designing Trials For Devices Targeting Neuro-Disease Progression: An FDA Guide
Executive Summary
The US agency finalized its guidance on IDEs for devices intended to treat the cause or progression, rather than just the symptoms, of neurological conditions like Alzheimer's.
You may also be interested in...
Guidance Offers IDE Tips For Devices Targeting Brain Disease Progression
FDA issued a draft guidance to help device-makers conduct clinical trials for products designed to slow the progress of neurological conditions. One challenge highlighted by the agency is that changes to biomarkers measured in a study may not line up easily with disease progression.
FDA Launches Pilot Program To Qualify Medical Device Development Tools
FDA is soliciting nominations from developers of tools to facilitate more predictable, efficient, and transparent regulatory evaluation of devices under a pilot program announced Aug. 15
Interview: Theradaptive To Enter Clinical Trial For Spinal Fusion Gel
Theradaptive, which makes a device-biologic combination product to help speed bone healing, recently got authorization to start human trials from the US FDA. Medtech Insight spoke to CEO Luis Alvarez about the company’s past, present and future.